Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Little Data to Support Wearable Device Health Benefits

A review of published research since 2000 shows little evidence to support claims of beneficial health outcomes from the use of wearable devices like smart watches or wristbands, at least not yet. . . . → Read More: Little Data to Support Wearable Device Health Benefits

FDA to Release More Accessible Clinical Trial Data

The U.S. Food and Drug Administration plans to make available in a more user-friendly format details from clinical trials of new drugs approved by the agency. . . . → Read More: FDA to Release More Accessible Clinical Trial Data

FDA Clears Targeted Breast Cancer Radiation Treatment

The U.S. Food and Drug Administration approved a device that sends high doses of radiation to cancerous breast tissue while sparing healthy tissue nearby. . . . → Read More: FDA Clears Targeted Breast Cancer Radiation Treatment

FDA Approves Gene Therapy for Inherited Vision Loss

A therapy using transfers of healthy genes to treat a rare form of inherited vision loss was approved today by the U.S. Food and Drug Administration. . . . → Read More: FDA Approves Gene Therapy for Inherited Vision Loss

FDA Issues Draft Precision Medicine Trial Guidance

The U.S. Food and Drug Administration issued draft regulatory guidance on clinical trials for new treatments that target genetic mutations rather than disease states. . . . → Read More: FDA Issues Draft Precision Medicine Trial Guidance

FDA Fast-Tracks Heart Failure Gene Therapy

A biotechnology company developing transfers of healthy genes to treat chronic diseases is receiving an accelerated review of its heart failure therapy from the U.S. Food and Drug Administration. . . . → Read More: FDA Fast-Tracks Heart Failure Gene Therapy

Current Drug Helps Cut Opioid Use After Surgery

Results from a clinical trial show patients given a current non-opioid pain medication with different types of surgery were less likely to use opioids for up to a year later. . . . → Read More: Current Drug Helps Cut Opioid Use After Surgery

CAR T-Cells Shown Effective in Long-Term Studies

Results from two clinical studies of engineered immune system cells show patients continue to respond their treatments after 6 months or more. . . . → Read More: CAR T-Cells Shown Effective in Long-Term Studies

PTSD Drug Trial Begins, Gets Fast-Track Status

An experimental drug that aims to keep nerve cells flexible is beginning an early-stage clinical trial as a treatment for post-traumatic stress disorder, or PTSD. . . . → Read More: PTSD Drug Trial Begins, Gets Fast-Track Status

FDA Approves Precision Solid Tumor Cancer Diagnostics

The Food and Drug Administration approved genomic tests for solid tumor cancers that identify the most promising available therapies matched to the tumor’s genetic mutations. . . . → Read More: FDA Approves Precision Solid Tumor Cancer Diagnostics